Faculty | CoBrCa – Controversies in Breast Cancer
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
GRAPES: A CANCER CELL INHIBITOR?
Transnational cancer research lab | Felsenstein Medical Research Center
Ribociclib Improves Progression-Free Survival for Women with Metastatic Breast Cancer
PLOS ONE: Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
Congratulations to Dr. Prasanna Alluri,... - UT Southwestern Radiation Oncology | Facebook
Prof.Salomon Stemmer
肿瘤专家团队- 垒登健康科技
Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
Salomon M Stemmer | Rabin Medical Center | Israel
Stemmer med våre salgstall
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
GRAPES: A CANCER CELL INHIBITOR?
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Can-Fite to Treat Advanced Liver Cancer Patients with Namodenoson Under Compassionate Use Setting in Israel | Business Wire
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
New Long-Term Outcomes Data Reconfirm Value of Oncotype DX Breast Recurrence Score® Test to Target Chemotherapy | WebMagspace
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Stemmer med våre salgstall
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN… https://t.co/3aAVqpqbMy"
The value of source data verification in a cancer clinical trial
